EA
AVNS icon

Emerald Acquisition’s Avanos Medical AVNS Stock Holding History

Emerald Acquisition’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$3M Sell
86,716
-64,102
-43% -$2.25M 0.01% 1525
2016
Q2 		$4.91M Buy
+150,818
New +$4.62M 0.01% 1328

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Emerald Acquisition's AVNS Position: Q3 2016 in Review

Emerald Acquisition reduced its Avanos Medical (AVNS) stake by 43% in Q3 2016, selling an estimated $2.25M and leaving 86,716 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #1525.

Emerald Acquisition first reported a position in AVNS in Q2 2016 and has held it in 2 quarters since. The position peaked at $4.91M in Q2 2016. 358 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

  • Emerald Acquisition held 86,716 shares of Avanos Medical worth $3M as of Q3 2016.
  • Emerald Acquisition sold 64,102 Avanos Medical shares in Q3 2016, an estimated $2.25M.
  • Avanos Medical made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1525 holding.
  • Emerald Acquisition first reported a position in Avanos Medical in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Avanos Medical position peaked at $4.91M in Q2 2016.
  • 358 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.